FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20367111000001105: Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68832301000001112 Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68832401000001116 Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Is a Generic Teysuno 15mg/4.35mg/11.8mg capsules true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has specific active ingredient Tegafur true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has specific active ingredient Gimeracil false Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has specific active ingredient Oteracil potassium true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Oteracil false Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Is a Teysuno true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has active ingredient Tegafur true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has specific active ingredient Gimeracil true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Oteracil true Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has basis of strength substance Oteracil true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) 126 capsule 9 x 14 capsules Has AMP True Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start